| All participants n = 443 |  < 50 years n = 399 |  ≥ 50 yearsn = 44 | p value |
---|---|---|---|---|
Study site | 0.18 | |||
 Kayunga, Uganda | 94 (21.2%) | 87 (21.8%) | 7 (15.9%) |  |
 South Rift Valley, Kenya | 105 (23.7%) | 90 (22.6%) | 15 (34.1%) |  |
 Kisumu West, Kenya | 51 (11.5%) | 47 (11.8%) | 4 (9.1%) |  |
 Mbeya, Tanzania | 123 (27.8%) | 108 (27.1%) | 15 (34.1%) |  |
 Abuja & Lagos Nigeria | 70 (15.8%) | 67 (16.8%) | 3 (6.8%) |  |
 Age at ART initiation (years), median (IQR) | 36.4 (30.5, 43.2) | 35.3 (29.9, 40.9) | 55.25 (52.4, 59.1) |  < 0.001 |
Gender | 0.07 | |||
 Male | 184 (41.5%) | 160 (40.1%) | 24 (54.5%) |  |
 Female | 259 (58.5%) | 239 (59.9%) | 20 (45.5%) |  |
Education |  < 0.01 | |||
 None or some primary | 118 (26.6%) | 97 (24.3%) | 21 (47.7%) |  |
 Primary or some secondary | 197 (44.5%) | 186 (46.6%) | 11 (25.0%) |  |
 Secondary and above | 128 (28.9%) | 116 (29.1%) | 12 (27.3%) |  |
Elevated blood pressure |  < 0.001 | |||
 No | 401 (90.5%) | 371 (93.0%) | 30 (68.2%) |  |
 Yes | 42 (9.5%) | 28 (7.0%) | 14 (31.8%) |  |
Dysglycemia | 0.63 | |||
 No | 367 (93.9%) | 332 (94.1%) | 35 (92.1%) |  |
 Yes | 24 (6.1%) | 21 (5.9%) | 3 (17.9%) |  |
Hypercholesterolemia | 0.10 | |||
 No | 358 (89.7%) | 326 (90.6%) | 32 (82.1%) |  |
 Yes | 41 (10.3%) | 31 (9.4%) | 7 (17.9%) |  |
CD4 nadir, median (IQR) | 259 (122.5, 389) | 257 (119.5, 384.5) | 326.5 (141, 545.5) | 0.22 |
ART regimen at initiation | 0.62 | |||
 TDF/EFV/3TC | 427 (96.4%) | 384 (96.2%) | 43 (97.7%) |  |
 Other | 16 (3.6%) | 15 (3.8%) | 1 (2.3%) |  |